MUMBAI, India and WALTHAM, Mass., March 9, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...

Sun Pharma announced Thursday morning that it is acquiring Concert Pharmaceuticals for $576 million. The Indian-based pharma company will acquire all outstanding shares of the late-stage biotech that ...

This is also Sun Pharma's second acquisition in less than three months and comes as the company looks to size up its specialty therapy portfolio. Sun Pharmaceutical Industries Ltd is buying US ...

Sun Pharmaceutical Industries Limited, India's top pharmaceutical company, has agreed to acquire Concert Pharmaceuticals Inc (NASDAQ: CNCE) for an upfront payment of $8.00 per share, or $576 ...

Sun Pharmaceutical Industries has lined up a $100 million investment to commercialise innovative products in the current fiscal, according to Chairman and Managing Director Dilip Shanghvi.

Drugmaker Sun Pharmaceutical Industries has completed the merger of Israel’s Taro Pharmaceutical Industries, ending a long drawn-out feud between the two companies, that played out across ...

Sun Pharmaceutical Industries Limited said that it will acquire the remaining 21.52% stake in Taro Pharmaceutical Industries. Sun Pharmaceutical Industries Limited on Thursday said that it will ...

BENGALURU, Aug 3 (Reuters) - Sun Pharmaceutical Industries (SUN.NS), opens new tab posted a nearly 2% fall in first-quarter profit on Thursday as higher expenses offset demand for its drugs and ...